The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.00
Bid: 296.00
Ask: 304.00
Change: -4.00 (-1.33%)
Spread: 8.00 (2.703%)
Open: 296.00
High: 299.00
Low: 296.00
Prev. Close: 300.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of JFN, Trading Update and Notice of Results

6 Mar 2023 07:00

RNS Number : 9282R
Fisher (James) & Sons plc
06 March 2023
 

This announcement contains inside information

6 March 2023

James Fisher and Sons plc

Sale of JFN, Trading Update and Notice of Results Announcement

 

James Fisher and Sons plc (FSJ.L) ('James Fisher', 'the Group'), the leading provider of marine services, announces that it has sold the entire issued share capital of James Fisher Nuclear Holdings Limited and related properties ("JFN", "the business"), to Myneration Limited, a wholly-owned investment vehicle of Rcapital Partners LLP ("Rcapital").

 

The sale forms part of the Board's ongoing commitment to rationalise and focus the Group's portfolio. Existing management and staff will remain with the business as it transitions into new ownership and Rcapital will provide JFN with a £3m secured revolving credit facility to fund the growth of the business going forward.

 

The Group has historically given a number of parent company guarantees to support the obligations of JFN. These guarantees will remain with James Fisher following completion of the transaction although certain limited counter-indemnities have been put in place. The Group has also received certain limited undertakings and information rights in respect of the principal parent company guarantee remaining in place following completion.

 

Following completion, an unsecured loan of £1.2m which has been made available by the Group to JFN will remain outstanding. It is anticipated that the amount outstanding under that loan will be repaid by JFN shortly after completion. In addition, the Group will make a secured interest-bearing term loan facility of up to £3.5m available to JFN. The Group has also entered into an inter-creditor agreement which sets out the priority of the facilities made available to JFN by Rcapital and the Group.

 

JFN is a supplier of specialist engineering, manufacturing and technical services to the UK's nuclear decommissioning industry. The results of JFN have historically been reported within the Specialist Technical division. The results of JFN will be shown as a Discontinued Operation in the Group's 2022 financial statements. In 2021, the business generated third party revenue of £51.7m and a loss before tax of £0.1m. At 30 June 2022 the unaudited gross assets of the business were approximately £36.4m and its net assets were approximately £17.5m, of which Goodwill represented £8.1m. The Group will sell its interest in James Fisher Nuclear Holdings Limited and certain group companies will sell their interests in the related properties for a nominal consideration of £3. As a result of the transaction the Group will impair the value of goodwill and tangible fixed assets associated with the business in its results for the year ended 31 December 2022.

 

Commenting on the sale, Chief Executive Officer, Jean Vernet, said:

"The sale of JFN is a further step in the implementation of our strategy to rationalise and focus the portfolio and, taken together, the business and asset disposals made over the last three months are important steps in streamlining the Group's operations and strengthening the balance sheet. JFN has some valuable and unique capabilities and requires the right investment to exploit the market opportunities in front of it. In Rcapital we are pleased to have found the right owner for the next chapter in this business's development. We wish the business and its employees every future success."

 

Josie Richardson, Investment Director at Rcapital, added:

"JFN plays a crucial role in the UK's nuclear decommissioning industry and, hence, the delivery of the Government's strategic energy plan. Its management team, market-leading technical services and unique UK-based experience in specialist fields put it in a strong position. We are pleased to have the opportunity to support the business as it enters a new phase of growth and development."

 

Trading update for the year ended 31 December 2022

The Group made good strategic and financial progress during 2022, disposing of three businesses, agreeing the sale of the Swordfish dive support vessel and generating good revenue and underlying operating profit growth across the Marine Support, Offshore Oil and Tankships divisions. The Specialist Technical division experienced a disappointing year, with JFD at a trough in its long-term projects cycle and JFN, which will be reported as a Discontinued Operation, reporting an operating loss following ongoing project challenges.

 

For the year ended 31 December 2022, the Group is expecting to report revenue from continuing operations of c.£475m (2021: £442.4m). Underlying operating profit from continuing operations is anticipated to be in line with 2021.

 

The three business sales completed in December 2022 generated gross proceeds of c.£18.4m. Net bank borrowings at 31 December 2022 were c.£135m, with the Group expecting to remain within its banking covenants. The sale of the Swordfish Dive Support Vessel, which was announced in December 2022, completed in January 2023, with cash proceeds of c.£20m now received. The Group has commenced discussions with its lending group regarding existing borrowing facilities, which have maturity dates ranging from October 2023 to September 2024.

Notice of Results Announcement

The Group's full year results will be published on 28 March 2023, two weeks later than had originally been planned, reflecting the significantly higher-than-normal levels of recent corporate activity and consequential impact on audit timetable.

 

 

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9500

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

 

The person responsible for making this announcement on behalf of the Company is Jean-François Bauer, Group General Counsel.

 

LEI: 213800J975E5OYR6S216

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSIEEIEDSEFD
Date   Source Headline
18th Apr 20191:07 pmRNSDirector/PDMR Shareholding
10th Apr 20194:32 pmRNSNotification of Directors' Interest in Shares
10th Apr 20194:30 pmRNSNotification of Directors' Interest in Shares
10th Apr 20194:28 pmRNSNotification of Directors' Interest in Shares
10th Apr 20194:25 pmRNSNotification of Directors' Interest in Shares
25th Mar 20192:21 pmRNSAnnual Report & Accounts
22nd Mar 20194:35 pmRNSAppointment of Senior Independent Director
20th Mar 201911:47 amRNSHolding(s) in Company
18th Mar 201910:58 amRNSDirector/PDMR Shareholding
18th Mar 20199:37 amRNSDirector/PDMR Shareholding
26th Feb 201910:00 amRNSDirectorate Change
26th Feb 20197:00 amRNSPreliminary Results
8th Jan 20197:00 amRNSACQUISITIONS OF MARTEK AND MSMC
19th Dec 20187:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
19th Dec 20187:00 amRNS£30m Submarine Rescue System contract
4th Dec 20187:00 amRNSRetirement of Chief Executive Officer
23rd Nov 20187:00 amRNSTrading Update
7th Nov 20184:32 pmRNSHolding(s) in Company
29th Aug 20187:00 amRNSHalf-year Results
13th Jul 20184:48 pmRNSHolding(s) in Company
21st Jun 201812:09 pmRNSAppointment of Senior Independent Director
15th Jun 201810:00 amRNSBlock Listing Six Montly Return
4th May 20183:00 pmRNSCORRECTION: Directors' Interest in Shares
3rd May 20183:39 pmRNSResult of AGM
3rd May 20187:00 amRNSTrading Update & AGM Statement
1st May 20187:00 amRNSTotal Voting Rights
10th Apr 20182:07 pmRNSNotification of Directors' Interest in Shares
10th Apr 20187:00 amRNS10 year, £50m Integrated Marine Services Contract
6th Apr 201811:50 amRNSDirector/PDMR Shareholding
5th Apr 20183:55 pmRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDirector/PDMR Shareholding
4th Apr 20189:39 amRNSTotal Voting Rights and Share Capital
9th Mar 201810:18 amRNSDirector/PDMR Shareholding
2nd Mar 20183:40 pmRNSDirector/PDMR Shareholding
2nd Mar 20187:00 amRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSNEW DIRECTOR APPOINTMENT
27th Feb 20187:00 amRNSPreliminary results year ended 31 December 2017
19th Feb 20187:00 amRNSAcquisition of Cowan Manufacturing PTY Limited
18th Jan 20187:00 amRNSBoard Changes
15th Dec 201710:57 amRNSBlock listing Interim Review
7th Dec 20174:57 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSACQUISITION OF EDS HV GROUP LIMITED
24th Nov 20177:00 amRNSTrading Update
14th Sep 20174:35 pmRNSPrice Monitoring Extension
30th Aug 20177:00 amRNSHalf Year Results 2017
25th Aug 201711:08 amRNSHolding(s) in Company
3rd Jul 20177:59 amRNSTotal Voting Rights and Share Capital
16th Jun 201711:11 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jun 20173:19 pmRNSDirector/PDMR Shareholding
7th Jun 20171:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.